Aisling Capital related stories
All articles and analysis
Valeant Pharma Buys Aton PharmaValeant Pharmaceuticals International (NYSE: VRX) has completed its $318 million acquisition of Aton Pharma Inc., a Lawrenceville, N.J.-based drug company focused on ophthalmology and certain orphan indications. Aton Pharma had raised over $37 million in VC funding from firms like Aisling Capital, HealthCare Ventures, Johnson & Johnson Development Corporation.
- peHUB Wire: Thursday, May 27, 2010
Random Ramblings
- peHUB Wire: Thursday, May 27, 2010
Random Ramblings
- peHUB WIre: Tuesday, May 11, 2010
Random Ramblings
- peHUB WIre: Tuesday, May 11, 2010
Random Ramblings
- Xanodyne Pharma Sells Lysteda, Refocuses on Pain Management
Xanodyne Pharmaceuticals Inc. has agreed to sell the global rights to Lysteda, a non-hormonal therapy indicated specifically for treatment of women with cyclic heavy menstrual bleeding, to Ferring Pharmaceuticals. No financial terms were disclosed for the deal, which Xanodyne says is part of a strategic refocusing on pain management drugs. Xanodyne has raised over $270 million in VC funding, including a $170 million Series A-1 round in 2005 that helped finance the $210 million acquisition of aaiPharma's pharmaceutical division out of bankruptcy. Backers include MPM Capital, AIG Investments, Aisling Capital, Blue Chip Venture Co., Essex Woodlands Health Ventures, HealthCare Ventures and Union Springs.
- Week in deals, May 3, 2010
Summary of tech companies and other startups in North America that raised venture financing in the past week
- Aragon Pharma Raises $22 Million
Aragon Pharmaceuticals Inc., a San Diego-based developer of treatments for hormonally-driven cancers, has raised $22 million in Series B funding. Aisling Capital was joined on the round by return backers OrbiMed Advisors and The Column Group.. Aragon previously raised around $8 million.
- peHUB Wire: Friday, April 23, 2010
Should Banks Invest in Private Equity?
- peHUB Wire: Friday, April 23, 2010
Should Banks Invest in Private Equity?